[New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine]

Vopr Virusol. 2011 Mar-Apr;56(2):36-9.
[Article in Russian]

Abstract

The amino acid and peptide derivatives of 1-adamantane carboxylic acid and rimantadine (18 compounds) have been first synthesized and investigated for their activity against influenza A virus (H1N1, H1N1v). In a series of obtained adamantine derivatives, some compounds have been found to be able to inhibit rimantadine-resistant influenza A virus strains. Thus, the antiviral properties of rimantadine can be restored.

Publication types

  • English Abstract

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / chemical synthesis
  • Adamantane / pharmacology
  • Adamantane / therapeutic use
  • Amantadine / analogs & derivatives
  • Amantadine / chemical synthesis
  • Amantadine / pharmacology
  • Amantadine / therapeutic use
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Drug Resistance, Viral / drug effects*
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza, Human / drug therapy*
  • Rimantadine / analogs & derivatives
  • Rimantadine / chemical synthesis
  • Rimantadine / pharmacology*
  • Rimantadine / therapeutic use

Substances

  • Antiviral Agents
  • Rimantadine
  • adamantanecarboxylic acid
  • Amantadine
  • Adamantane